Since its establishment, the unit has established a complete evaluation platform for early clinical trials of new drug. It designed different clinical trial protocols based on disease characteristics, clinical needs and drug targets; During the study, the initial dose and effective dose were estimated by using quantitative pharmacology model; The unit optimizes the design of early clinical trials, shortens the running time of trials, quickly enters clinical trials for patients, verifies efficacy as soon as possible, and accelerates the pace of new drug launches. The unit established a glucose clamp platform in 2020, and has purchased equipment and completed staff training.